Newsroom

Vascudyne Image

Vascudyne Receives BioBusiness Award from Regenerative Medicine Minnesota for Treatment of Nerve Injury

VASA Conference Image

Vascudyne Announces Presentation of First Clinical Results of TRUE AVC™ in Hemodialysis Access at the VASA Conference

Vascudyne Lab

Regenerative Medicine Company Vascudyne Relocates to High Capacity GMP Manufacturing Facility

Autm better world project image

Vascudyne’s TRUE Tissue Technology is a Top 3 2022 Better World Project Award Finalist

Regenerative Medicine Vascular Graft for Hemodialysis Access

Regenerative Medicine Company Vascudyne Closes $10M Series A Financing

Vascudyne announces successful First Human Use of TRUE™ Vascular Graft for hemodialysis access

Vascudyne’s CSO presents at the Heart Valve Society Meeting on tissue remodeling of engineered valved conduit evaluated at 52 weeks in the growing lamb

Lab-created heart valves can grow with the recipient article published in Science Translational Medicine

Vascudyne is awarded Regenerative Medicine Minnesota grant on transcatheter regenerative tissue pulmonary valve project

Vascudyne exhibits at DeviceTalks in Minnesota

Vascudyne’s CSO presents at the Heart Valve Society Meeting on engineered tissue transcatheter valve for pulmonary and tricuspid valve implant

Vascudyne is awarded Regenerative Medicine Minnesota grant on development of regenerative engineered tissue embedded cardiovascular device project

University of Minnesota startup Vascudyne to commercialize biologic engineered tissue with potential to transform medical device technology

New tissue-engineered blood vessel replacements closer to human trials article published in Science Translational Medicine

Artificial blood vessels developed in the lab can grow with the recipient article published in Nature Communications

Proud Member of:

6 + 2 =

Copyright 2021 | Vascudyne, Inc.